title: [Circadian profile of the prolactin concentration in the patients with end-stage renal failure].
abstract: Determination of circadian of prolactine (PRL) profile and its relationship to selected clinical and laboratory indices in end-stage renal disease (ESRD) patients undergoing hemodialysis, peritoneal dialysis as well as those in predialysis period was the aim of the study. Investigations were carried out in 38 patients with ESRD aged 36 to 79 yr. (medium 59 +/- 11 yr.), (20 male, 18 female, 7 treated with peritoneal dialysis, 25 undergoing hemodialysis, 6 in predialysis period) and the control group consisting of 7 healthy volunteers (4 male and 3 female). Serum concentration of PRL was evaluated at 3:00, 7:00, 12:00, 18:00, 22:00. The influence of different dialysis methods, blood concentration of parathormone, hemoglobin, total protein, erytropoietin (EPO), C-reactive protein, EPO therapy and duration of dialysis therapy on the PRL profile was analyzed. Results were analyzed according to medium obtained values of daily PRL profiles and individual indexes of variation of the daily concentration. Impaired circadian PRL profile was found in the all of followed groups comparing to the control, which was based on flatting of the curve and decreasing of the nightly pick of secretion PRL. None of analyzed factors had normalized the PRL profile curve.
  
  
  CONCLUSIONS
  The PRL profile in ESRD patients treated with hemodialysis, peritoneal dialysis and in predialysis period is changed. The PRL profile curve is flatted and there was no night pick of PRL secretion in the patients. PRL level was shown to increase with progress of the disease, and the highest levels were in hemodialysed patients. EPO treatment, general appearance improvement, increased hemoglobin level and any of studied different dialysis method did not normalize the altered PRL profile.
authors.affiliation: Oddział Chorób Wewnetrznych ze Stacja Dializ SZP ZOZ w Wołominie. nephro@amwaw.edu.pl
authors.forename: Stanisław
authors.initials: S
authors.lastname: Niemczyk
authors.forename: Joanna
authors.initials: J
authors.lastname: Matuszkiewicz-Rowińska
authors.forename: Katarzyna
authors.initials: K
authors.lastname: Szamotulska
authors.forename: Longin
authors.initials: L
authors.lastname: Niemczyk
authors.forename: Paweł
authors.initials: P
authors.lastname: Kulicki
authors.forename: Grzegorz
authors.initials: G
authors.lastname: Ostrowski
authors.forename: Anna
authors.initials: A
authors.lastname: Zalewska-Waśniewska
authors.forename: Zofia
authors.initials: Z
authors.lastname: Sitkowska-Kurzec
mesh_terms: D000328:Adult; D000368:Aged; D002097:C-Reactive Protein / Q000032:analysis; D016022:Case-Control Studies; D002940:Circadian Rhythm; D004921:Erythropoietin / Q000097:blood; D005260:Female; D006801:Humans; D007676:Kidney Failure, Chronic / Q000097:blood*; D008297:Male; D008875:Middle Aged; D010281:Parathyroid Hormone / Q000097:blood; D010530:Peritoneal Dialysis; D011388:Prolactin / Q000097:blood*; D011506:Proteins / Q000032:analysis
chemical_list: D010281:Parathyroid Hormone; D011506:Proteins; D004921:Erythropoietin; D011388:Prolactin; D002097:C-Reactive Protein